an update for families
We previously shared that families only needed to join one study. Since then, both studies have grown, and each is now focused on different research questions. While both teams are working to harmonize data collection across sites in the future, this process is very complex.
For now, families are welcome (and encouraged!) to join both studies.
enroll in a natural history study
The UCSF COL4A1/2 Natural History Study
Led by Dr. Rachel Vassar, this study follows people with COL4A1 and COL4A2 variants to understand the full picture of Gould Syndrome: the range of features people experience, from brain and eye to kidney and muscle, and how they change over time.
UCSF is also home to the Gould Syndrome Center, the first clinical center dedicated to Gould Syndrome.*
at a glance
Study Focus: The study wants to understand the full range of Gould Syndrome at every age. It looks at the whole body, with extra focus on the brain and blood vessels, to assess how symptoms evolve over a 5-10 year period.
Where: UCSF Benioff Children's Hospital in San Francisco, California or remotely
What's involved:
Sharing medical records and answering questions about how you're doing
Patients may have the option to provide blood or fibroblast samples in the future
Follow-up: at least once a year for 5 to 10 years
Cost: none
You're welcome to join this study even if you're already in the MGH study.
The Young Genetic Stroke Alliance: A Natural History with Biomarkers of Hereditary Cerebrovascular Disorders
Dr. Musolino and Dr. Gould are working in parallel on developing gene therapies to help patients with Gould Syndrome.* This ongoing study aims to evaluate the natural history of disease associated with COL4A1 and COL4A2 variants and establish clinical biomarkers that may serve as future clinical trial endpoints.
at a glance
Study Focus: The study's focus is clinical trial readiness: how the condition progresses, what to measure, and which patients may benefit. It's part of the Young Genetic Stroke Alliance, which studies several genetic causes of stroke.
Where: Massachusetts General Hospital (MGH) in Boston, Massachusetts or remotely
What's involved:
Sharing medical records and prior imaging
Local patients can provide (optional) blood or skin samples at MGH
Follow-up: yearly or sooner, depending on the person
Cost: none
You're welcome to join this study even if you're already in the UCSF study.
*Please note that participation in a natural history study will not impact your medical care. If you are interested in scheduling a clinical appointment (second opinion) at MGH or UCSF, please mention this to your research coordinator or contact your PCP for a referral.
FREQUENTLY ASKED QUESTIONS
-
Both studies accept patients from anywhere in the world with a confirmed COL4A1 or COL4A2 variant that is labeled as pathogenic, likely pathogenic, or VUS (Variant of Unknown Significance).
If you are interested in joining a study, please fill out the enrollment interest form.
-
Both studies accept patients with VUS - for more information about your specific variant, please reach out to the study team(s).
-
Both, if you can! Each study asks different questions, so joining both helps research at two leading centers, but you’re welcome to choose just one.
Both studies are free, open to families worldwide, and can be done remotely, mostly by sharing medical records. To learn more, check each study’s page.
-
Both studies can be done remotely.
-
Yes! Please fill out a separate enrollment inquiry for each individual family member.
-
Your family’s information is kept confidential. When you enroll, you’ll sign a form giving the study team permission to use your or your child’s medical records for research. In the research data, names are replaced with a code. Each study is overseen by an ethics review board, and published results don’t include names.
If you live outside the US, your country’s privacy laws may also apply. The study teams can walk you through the details.
-
Yes. Over time, findings from both studies will be published and shared with doctors, researchers, and families everywhere to improve how Gould Syndrome is understood and cared for. But because Gould Syndrome is rare, every family who joins makes the findings stronger, so we encourage you to take part.
-
Results will be shared through publications and TGSF updates.
-
Enrollment in a natural history study will not change your current medical care.
Both UCSF and MGH offer clinical care for patients with Gould Syndrome. If you are interested in a consult or second opinion, please discuss with your/your child’s primary care provider for a referral or ask your research coordinator for more information.
Participation in a natural history study does not guarantee an appointment.
Questions for TGSF? research@gouldsyndromefoundation.org

